Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Moderna

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Experts say there are a number of factors to weigh up about getting a fourth dose of a COVID-19

As millions more people become eligible for a fourth COVID vaccine dose, you might be asking whether you should book in for it or wait for Omicron-specific vaccines still being developed.

ABC News

Thinking of mixing and matching COVID-19 vaccine booster shots? There doesn't seem to be much point

Most people will have the Moderna or the Pfizer vaccine for their fourth dose. But the Doherty Institute's head of vaccine and immunisation research says there's practically no difference between them.

ABC News

From analysis to the latest developments in health,
read the most diverse news in one place.

Omicron boosters could be here by fall

As viruses morph and adapt, there's a greater call for targeted vaccines and boosters

Salon

COVID boosters: When Australians might be able to get their fourth jabs

With a third Omicron wave approaching, the wider Australian population may soon be able to get their second COVID booster shots.

The New Daily

This Is What Whales Are Betting On Moderna

Benzinga

COVID vaccines: our current shots could soon be updated to target new variants – an immunology expert explains

More than two years into the pandemic, SARS-CoV-2, the virus that causes COVID-19, continues to challenge us. Its ability to rapidly mutate has seen the evolution of increasingly infectious variants that are getting better at hiding from our immune response.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Peering Into Moderna's Recent Short Interest

Moderna's (NASDAQ:MRNA) short percent of float has fallen 4.65% since its last report. The company recently reported that it has 14.76 million shares sold short, which is 4.31% of all regular shares that are available for trading.

Benzinga

New 'super booster' Covid vaccine could be approved for use in UK within days

Moderna has created a new type of jab, codenamed 214, which is said to be more effective than previous vaccines, according to reports

Chronicle Live

30million people could get new Covid super booster codenamed 214

The jab engineered to tackle the new variants causing a summer wave is expected to be approved for use in the UK

Wales Online

What’s the UK’s booster policy ahead of a feared autumn Covid wave?

Tweaked vaccines to tackle Omicron are in trials as JCVI finalises advice for vulnerable groups

The Guardian - UK

New Moderna 'super-booster' jab to target Wuhan and Omicron strains 'coming in Autumn'

The jab, known as “214”, is bivalent, which means it helps build immunity to both the original Wuhan strain and the Omicron variants

Daily Mirror

Covid: Urgent call to update vaccines to target variants as cases rise to near-record levels

The case is growing to tweak the jabs to target more tranmissible Omicron variants, experts say

The Independent UK

What Are Whales Doing With Moderna

A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 19 strange trades.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

FDA says COVID boosters for the fall must target newer omicron types

With immunity waning and the super-contagious omicron family of variants getting better at dodging protection, the Food and Drug Administration decided boosters intended for fall needed an update.

The Independent UK

Tweaked COVID boosters in US must target newer omicron types

U.S. regulators are telling COVID-19 vaccine makers to tweak any booster doses intended for fall so they protect against the newest omicron relatives

Chicago Sun-Times

COVID vaccination reboot coming this fall to add tweaks for new coronavirus variants

The FDA will have to decide the exact recipe. But expect a combination shot that adds protection against omicron or some of its newer relatives to the original vaccine.

Benzinga

Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline'

The Food and Drug Administration’s panel of independent vaccine experts recently voted 19 to 2 to recommend a new batch of COVID-19 booster shots targeting the omicron variant this fall. The news, announced Tuesday, June 28, could have a big impact on the share prices of vaccine makers.

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Detroit makes COVID vaccines available for children 6 months to 5 years

DETROIT — The city is providing COVID vaccines from Pfizer and Moderna for children ages 6 months up to 5 years of age, following emergency authorization from the federal Food and Drug Administration and approval from the state health department.

Tribune News Service

COVID shots should get omicron-targeted update, FDA advisers say

COVID-19 shots from Pfizer Inc. and Moderna Inc. should be updated to include components that target the highly transmissible omicron variant, the version of the virus that causes most of the world’s cases, U.S. regulatory advisers said.

The Conversation

Canada needs to invest more money into science innovation to help prevent the next global crisis

Canada has lagged behind its peer nations in innovation for decades. Currently, Canada is ranked 11th out of the 16 similarly developed countries assessed. While our “C” grade is a moderate improvement over our previous “D” grade, innovation still remains a barrier to high-quality job creation and economic prosperity in…

The Independent UK

US grapples with whether to modify COVID vaccine for fall

U.S. health authorities are facing a critical decision: whether to offer new COVID-19 booster shots this fall that are modified to better match the latest changes of the shape-shifting coronavirus

Benzinga

What Are Whales Doing With Moderna

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 13 strange trades.

Benzinga

Walmart And 3 Other Stocks Insiders Are Selling

US stock futures traded slightly higher this morning on Monday after recording sharp gains in the previous session. Investors, meanwhile, focused on some notable insider trades.

The Conversation

Should you get a COVID-19 booster shot now or wait until fall? Two immunologists help weigh the options

While COVID-19 vaccines continue to be highly effective at preventing hospitalization and death, it has become clear that the protection offered by the current vaccines wanes over time. This necessitates the use of booster shots that are safe and effective in enhancing the immune response against the virus and extending…

1 … 21 22 23 24

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.